abstract |
The invention provides antibodies that specifically bind to seven human ELR + CXC chemokines. The antibodies of the invention are useful for the treatment of various inflammatory/autoimmune diseases such as inflammatory bowel disease (IBD), plaque psoriasis and palmoplantar impetigo, and cancer (such as kidney or ovarian cancer). |